Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Nawa

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|May 31, 2023
<i>De Novo</i> Design of Nurr1 Agonists <i>via</i> Fragment-Augmented Generative Deep Learning in Low-Data RegimeMarco Ballarotto, Sabine Willems, Tanja Stiller, et al.
Journal of Medicinal Chemistry|July 24, 2025
Development of an RXR Agonist Scaffold with Pronounced Homodimer PreferenceFelix Nawa, Arthur Kardanov, Till Kasch, et al.
Journal of Medicinal Chemistry|November 24, 2025
Structural Tuning of Partial RXR Agonism and AntagonismMax Lewandowski, Marie Granger-Rivière, Domenic Mayer, et al.
Journal of Medicinal Chemistry|September 11, 2024
Tuning RXR Modulators for PGC1α RecruitmentFelix Nawa, Minh Sai, Jan Vietor, et al.
Journal of Medicinal Chemistry|December 8, 2023
Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist PotencyGustave Adouvi, Felix Nawa, Marco Ballarotto, et al.
Journal of Medicinal Chemistry|July 31, 2024
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 AgonismSabine Willems, Romy Busch, Felix Nawa, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|May 31, 2023
<i>De Novo</i> Design of Nurr1 Agonists <i>via</i> Fragment-Augmented Generative Deep Learning in Low-Data RegimeMarco Ballarotto, Sabine Willems, Tanja Stiller, et al.
Journal of Medicinal Chemistry|July 24, 2025
Development of an RXR Agonist Scaffold with Pronounced Homodimer PreferenceFelix Nawa, Arthur Kardanov, Till Kasch, et al.
Journal of Medicinal Chemistry|November 24, 2025
Structural Tuning of Partial RXR Agonism and AntagonismMax Lewandowski, Marie Granger-Rivière, Domenic Mayer, et al.
Journal of Medicinal Chemistry|September 11, 2024
Tuning RXR Modulators for PGC1α RecruitmentFelix Nawa, Minh Sai, Jan Vietor, et al.
Journal of Medicinal Chemistry|December 8, 2023
Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist PotencyGustave Adouvi, Felix Nawa, Marco Ballarotto, et al.
Journal of Medicinal Chemistry|July 31, 2024
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 AgonismSabine Willems, Romy Busch, Felix Nawa, et al.
Pageof 1